Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients

Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients

Objective: Tolvaptan, a vasopressin V2 receptor antagonist, is an oral diuretic. Patients with terminal cancer develop marked fluid retention, and oral diuretics other than tolvaptan have been used as treatments without clear therapeutic effects. Herein, we aimed to study the efficacy and safety of...

Full description

Bibliographic Details
Main Authors: Norimasa Tsuzuki, Masanobu Usui, Akihiro Itoh, Akihiko Futamura, Kazuki Imai
Format: Article
Language:English
Published: Fujita Medical Society 2023-02-01
Series:Fujita Medical Journal
Subjects:
tolvaptan
palliative medicine
terminal cancer
edema
Online Access:https://www.jstage.jst.go.jp/article/fmj/9/1/9_2021-005/_pdf/-char/en

Internet

https://www.jstage.jst.go.jp/article/fmj/9/1/9_2021-005/_pdf/-char/en

Similar Items